ARCHIVES

In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC

This article is from The Cancer Letter archive.

Vol. 24 No. 33 | September 4, 1998

Download PDF Visit The Full Archive

Related Articles

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

NCI Releases List of Cancer Center Core Grant Funding for FY 2005; Univ. of New Mexico is the Newest NCI-Designated Center.

March 3, 2006

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

NCI-Approved Clinical Trials

February 24, 2006

Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program

October 31, 2014

NCAB Approves OIA Awards For At Least 21 Scientist, More If Payline Lifted

May 24, 1985